Cognitive science

New Study Publication Demonstrates Eye Health and Cognitive Benefits of Lutein and Zeaxanthin from Lutemax Kids

Retrieved on: 
Wednesday, February 21, 2024

BRIDGEWATER, N.J. and MUMBAI, India , Feb. 21, 2024 /PRNewswire/ -- Six in ten parents regularly worry about their child's eye health, prioritizing it above other well-being needs; however, they are unfamiliar with ways to support it. This finding is according to a OmniActive Health Technologies U.S. parent survey for its "Lutein for Every Age" educational initiative, which focuses on raising awareness of early and consistent lutein and zeaxanthin intake to help support eye, cognitive, and general health throughout life.

Key Points: 
  • The publication revealed that Lutemax Kids resulted in significant improvements in aspects of vision performance and cognition.
  • "This study is an important milestone for eye health and cognitive science, laying the groundwork for further understanding on how lutein and zeaxanthin can impact younger populations.
  • Lutemax Kids , a line extension of OmniActive's pioneering lutein and zeaxanthin extract brand Lutemax 2020, is a lower dose to help meet the nutritional needs of children.
  • To learn more about how to support eye and brain health visit Lutemax.com/lfea and to find supplements that feature the Lutemax ingredient, visit Lutemax.com/where-to-buy .

Alzheimer's Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Retrieved on: 
Tuesday, February 13, 2024

BOSTON, Feb. 13, 2024 /PRNewswire/ -- A proprietary cognitive assessment from Linus Health, a digital health company focused on enabling early detection of Alzheimer's and other dementias, outperforms the most commonly used paper-based assessment in detecting early mild cognitive impairment and dementia and with less ethnic and racial bias, according to a peer-reviewed study recently published in the prestigious medical journal Alzheimer's Research & Therapy.

Key Points: 
  • The body of research confirms the most recent findings that the DCR outperforms a commonly used traditional cognitive test, the MMSE, in detecting early signs of cognitive impairment, and is more accurate overall in classifying mild cognitive impairment and mild dementia.
  • More than 80% of Americans are unfamiliar with mild cognitive impairment, which can be an early stage of Alzheimer's Disease, according to the Alzheimer's Association.
  • Symptoms are also not always noticeable, leading to delayed screenings and potentially greater risk to patients' brain health.
  • In contrast, the DCR was able to detect cognitive impairment in more than 80% of those the MMSE misclassified.

Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome

Retrieved on: 
Wednesday, January 31, 2024

Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, including those that affect sizeable patient populations, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) Application for JAG201, a gene therapy for a genetic form of autism spectrum disorder (ASD) and Phelan-McDermid syndrome (PMS).

Key Points: 
  • Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, including those that affect sizeable patient populations, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) Application for JAG201, a gene therapy for a genetic form of autism spectrum disorder (ASD) and Phelan-McDermid syndrome (PMS).
  • JAG201 aims to deliver functional SHANK3 via the AAV9 vector to treat the root cause of the disease.
  • “We are pleased to receive FDA clearance to bring our investigational SHANK3 gene therapy to the clinic.
  • The pre-clinical data indicate that JAG201 may have the potential to be transformative for those suffering with the disorder,” said Joe Nolan, chief executive officer of Jaguar Gene Therapy.

The Franklin Institute Celebrates 200 Years of Recognizing Excellence in Science and Technology with Announcement of 2024 Franklin Institute Awards Laureates

Retrieved on: 
Tuesday, January 30, 2024

As part of its bicentennial celebrations, The Franklin Institute proudly announces the laureates of the 200th year of the Awards Program.

Key Points: 
  • As part of its bicentennial celebrations, The Franklin Institute proudly announces the laureates of the 200th year of the Awards Program.
  • Since its inception, The Franklin Institute Awards Program has honored the most influential scientists, engineers, and inventors who have significantly advanced science and technology.
  • Bank of America returns in 2024 as the Presenting Sponsor of The Franklin Institute Awards Ceremony and Dinner for the 22nd consecutive year.
  • For more information about The Franklin Institute Awards Program and the 2024 laureates, please visit fi.edu/awards.

Global Recognition for NOLEJ - The French Edtech Snaps the World Best Edtech Start-Up Award at the BETT in London, With its Transformative Generative AI for Education

Retrieved on: 
Tuesday, January 30, 2024

NOLEJ doubles down on its early success as European frontrunner in applying generative AI in education.

Key Points: 
  • NOLEJ doubles down on its early success as European frontrunner in applying generative AI in education.
  • This accolade is a testament to NOLEJ's commitment to reshaping the educational landscape empowering teachers and instructional designers with Ethical Generative AI capabilities.
  • The award serves as a launching pad, propelling NOLEJ toward the realization of its global ambitions," said Nejma Belkhdim, Co-founder and CPO at NOLEJ.
  • NOLEJ AI is designed to revolutionize the future of learning by addressing the limitations of traditional education frameworks.

Carnegie Foundation Welcomes Brooke Stafford-Brizard as Vice President for Innovation and Impact

Retrieved on: 
Wednesday, January 17, 2024

STANFORD, Calif., Jan. 17, 2024 /PRNewswire/ -- The Carnegie Foundation for the Advancement of Teaching (Carnegie) is pleased to announce that Brooke Stafford-Brizard will join the organization as vice president for innovation and impact.

Key Points: 
  • STANFORD, Calif., Jan. 17, 2024 /PRNewswire/ -- The Carnegie Foundation for the Advancement of Teaching (Carnegie) is pleased to announce that Brooke Stafford-Brizard will join the organization as vice president for innovation and impact.
  • As vice president at Carnegie, Stafford-Brizard will leverage her multifaceted career to cultivate and steward cross-sector partnerships to accelerate the foundation's mission.
  • "Brooke embodies our commitment to catalyzing transformational change in education by fostering innovative, evidence-based practices," said Timothy F.C.
  • Most recently, Stafford-Brizard served as vice president for research to practice at the Chan Zuckerberg Initiative.

Pacific Northwest Fertility Center, an Ivy Fertility Clinic Hires Dr. Hanh N. Cottrell

Retrieved on: 
Wednesday, December 6, 2023

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Hanh N. Cottrell, MD to its team of physicians at Pacific Northwest Fertility.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Hanh N. Cottrell, MD to its team of physicians at Pacific Northwest Fertility.
  • “We are so proud to welcome Dr. Cottrell to our team,” said Julie Lamb, MD, medical director at Pacific Northwest Fertility.
  • “I’m sincerely excited to be joining the like-minded, compassionate, and creative individuals at PNWF and Ivy Fertility,” said Dr. Cottrell.
  • “I believe every patient deserves a personalized touch to their fertility care and am looking forward to providing that as a member of the Pacific Northwest Fertility team.”

Carnegie Learning Announces LiveHint AI™

Retrieved on: 
Thursday, November 30, 2023

Carnegie Learning has spent 25 years researching how the human brain learns best and building educational solutions that align closely to the ACT-R cognitive architecture: the world’s most comprehensive theory of how the mind works, developed by Carnegie Learning co-founder John Anderson .

Key Points: 
  • Carnegie Learning has spent 25 years researching how the human brain learns best and building educational solutions that align closely to the ACT-R cognitive architecture: the world’s most comprehensive theory of how the mind works, developed by Carnegie Learning co-founder John Anderson .
  • The Carnegie Learning team responsible for LiveHint AI is led by Dr. Steve Ritter , the Chief Scientist and one of the company’s co-founders.
  • Barry Malkin, CEO of Carnegie Learning, remarked, "It's with immense pride that we introduce LiveHint AI today.
  • With the introduction of LiveHint AI, Carnegie Learning continues to lead the charge in AI and education, collaborating with the top researchers in the world to push the boundaries of AI's potential to enhance student learning experiences.

Berkeley Haas Launches O'Donnell Center for Behavioral Economics to Lead the Next Generation of Research

Retrieved on: 
Monday, November 20, 2023

The center will also host the prestigious Behavioral Economics Annual Meeting (BEAM), co-founded by Malmendier, every three years.

Key Points: 
  • The center will also host the prestigious Behavioral Economics Annual Meeting (BEAM), co-founded by Malmendier, every three years.
  • O’Donnell says he was inspired by the pioneering work of Kahneman, Akerlof, Malmendier, and others who gave Berkeley its leading position in behavioral economics.
  • “It should have a center devoted to continuing this work.”
    The center, says Berkeley Haas Dean Ann E. Harrison, will create a far-reaching impact across UC Berkeley, a research powerhouse with many areas of strength.
  • The center will also involve a host of affiliated researchers from Berkeley Haas and Berkeley Economics, as well as from across the university.

NOLEJ, a Trailblazer in AI Solutions for Education, Has Secured 3 Million Euros in Funding, Accelerating Its Expansion

Retrieved on: 
Wednesday, December 6, 2023

The funding round, led by Educapital and Square Knowledge Ventures, is a pivotal milestone in NOLEJ's growth trajectory.

Key Points: 
  • The funding round, led by Educapital and Square Knowledge Ventures, is a pivotal milestone in NOLEJ's growth trajectory.
  • A study by eLearning Guild shows that 75% of conventional course materials don't meet current student needs.
  • NOLEJ AI helps educators generate interactive eLearning modules up to 50 times faster than traditional methods.
  • Jonathan Denais, Investment Director at Educapital, asserts, "NOLEJ stands out as a European frontrunner in applying generative AI in education.